These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3000014)

  • 21. Valsartan: new preparation. Just a second-line antihypertensive drug.
    Prescrire Int; 1998 Oct; 7(37):144-5. PubMed ID: 10915419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-II receptor antagonists: a new class of antihypertensive agents.
    Weir MR
    Am Fam Physician; 1996 Feb; 53(2):589-94. PubMed ID: 8629540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A review of recent pharmacological therapeutic principles in hypertension].
    Andrén L; Dahlöf B; Eggertsen R; Gudbrandsson T; Hansson L; Jern S; Sivertsson R; Svensson A
    Lakartidningen; 1983 Mar; 80(10):945-58. PubMed ID: 6191162
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypertension--new drug therapies. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure.
    Solomon J
    RN; 1994 Jan; 57(1):26-32; quiz 33. PubMed ID: 7905659
    [No Abstract]   [Full Text] [Related]  

  • 25. New challenges in the disease management of hypertension.
    Laurent S; Zanchetti A
    J Hypertens Suppl; 2001 Sep; 19(3):S1. PubMed ID: 11713845
    [No Abstract]   [Full Text] [Related]  

  • 26. Modern concepts in the drug treatment of arterial hypertension.
    van Zwieten PA
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):412-9. PubMed ID: 6108920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS; Christensen S
    Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical guidelines for the use of converting enzyme inhibitors in congestive heart failure.
    Dickstein K
    Int J Cardiol; 1987 Apr; 15(1):1-5. PubMed ID: 3032812
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The therapy of arterial hypertension: a comparison between ACE inhibitors and angiotensin-II-receptor antagonists].
    Rossi F; Mangrella M; Paternò E; Imperatore F; Capristo M; Imperatore C; Guarino A
    Clin Ter; 1996 Oct; 147(10):475-88. PubMed ID: 9264900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aliskiren for hypertension in adults.
    Drug Ther Bull; 2008 Oct; 46(10):73-6. PubMed ID: 18832257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Angiotensin-converting enzyme inhibitors in the treatment of hypertension in Air Force personnel].
    Godilo-Godlevskiĭ VA; Nagovitsyn AV; Toporishcheva OS; Vovkodav VS
    Voen Med Zh; 2009 May; 330(5):55-7. PubMed ID: 19663210
    [No Abstract]   [Full Text] [Related]  

  • 35. [Despite antihypertensive medication every 4th patient has elevated blood pressure values in the morning].
    MMW Fortschr Med; 2002 Jul; 144(29-30):54. PubMed ID: 12219615
    [No Abstract]   [Full Text] [Related]  

  • 36. [Forum on hypertension. Part 5. New anti-hypertensive agents in the therapy of hypertension].
    Holzgreve H
    MMW Munch Med Wochenschr; 1981 May; 123(21):suppl 80-6. PubMed ID: 6265766
    [No Abstract]   [Full Text] [Related]  

  • 37. ACE inhibitors and stroke: new considerations.
    Sica DA
    J Clin Hypertens (Greenwich); 2002; 4(2):126-9, 133. PubMed ID: 11927795
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Esnault VL
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846229
    [No Abstract]   [Full Text] [Related]  

  • 40. Benefits of angiotensin converting enzyme inhibition and angiotensin II receptor antagonists in hypertension.
    Conlin PR
    J Med Liban; 2000; 48(6):382-6. PubMed ID: 11503531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.